High-dose Insulin Euglycemia Therapy (HIET)
ورودیهای بالینی بیمار
حداقل ۱ — حداکثر ۵۰۰ • واحد: kg
پارامترهای بالینی بیمار را در فرم روبرو وارد کنید و روی «محاسبه» کلیک نمایید تا نمره، طبقه خطر و اقدامات فوری نمایش داده شوند.
- HIET Protocol0–999
The High-dose Insulin Euglycemia Therapy (HIET) calculates calculating insulin dosing for calcium channel blocker or beta blocker overdose. Key inputs include weight. Scores guide administering specific antidote therapy, gastrointestinal decontamination, and continuous telemetry monitoring. This standardized assessment improves clinical decision safety and bedside patient management.
Clinical Guidelines & Evidence
Calculates insulin dosing for calcium channel blocker or beta blocker overdose. Provides both initial bolus and continuous infusion doses, along with dextrose requirements to maintain euglycemia.
Clinical Indication
The High-dose Insulin Euglycemia Therapy (HIET) is indicated for bedside clinical practice to support Calculates insulin dosing for calcium channel blocker or beta blocker overdose. Provides both initial bolus and continuous infusion doses, along with dextrose requirements to maintain euglycemia.. It assists healthcare providers in standardizing clinical assessment and therapeutic decision-making.
Target Population
Target population comprises Patients presenting with acute pharmaceutical overdose, agricultural pesticide ingestion, toxic gas inhalation, or venomous envenomation. Clinical application is indicated across Poison control centers, acute toxicology wards, emergency resuscitation rooms, and intensive care.
Limitations & Contraindications
Initial serum concentrations for sustained-release or co-ingested anticholinergic agents may falsely appear low before delayed absorption peaks.
Clinical Pearls & Action Plan
Rapid clinical toxidrome identification guides immediate antidote administration; do not wait for confirmatory toxicology assays.
Insulin Bolus = 1 unit/kg IV; Initial Infusion = 0.5-1 unit/kg/hr; Dextrose = 0.5 g/kg/hr
Input Parameters
| Name | Type | Required | Description |
|---|---|---|---|
| weight | float | Yes | Patient weight(kg) |
| infusion_rate | string | Yes | Initial insulin infusion rate |
Score Interpretation & Guidance
| Range | Stage | Description |
|---|---|---|
| 0–999 | HIET Protocol | Dosing calculated |
Evidence-Based References (EBM)
- Holger JS, Stellpflug SJ, Cole JB, Harris CR, Engebretsen KM. High-dose insulin: a consecutive case series in toxin-induced cardiogenic shock. Clin Toxicol (Phila). 2011 Aug;49(7):653-8.
- Greene SL, Gawarammana I, Wood DM, Jones AL, Dargan PI. Relative safety of hyperinsulinaemia/euglycaemia therapy in the management of calcium channel blocker overdose: a prospective observational study. Intensive Care Med. 2007 Nov;33(11):2019-24.
- Engebretsen KM, Kaczmarek KM, Morgan J, Holger JS. High-dose insulin therapy in beta-blocker and calcium channel-blocker poisoning. Clin Toxicol (Phila). 2011 Apr;49(4):277-83.